Modulation of monocyte subsets in infectious diseases

被引:0
|
作者
Mignane B Ka [1 ,2 ]
Daniel Olive [1 ]
Jean-Louis Mege [2 ]
机构
[1] Inserm Unité Mixte de Recherche(UMR) 1068,Centre de Recherche en Cancérologie de Marseille,13009 Marseille,France
[2] Department of Immunology and Infectious Diseases,Aix Marseille University,URMITE,UM63,CNRS 7278,IRD 198,INSERM 1095,13005 Marseille,France
关键词
Monocytes subsets; Infection; Virus; Bacteria;
D O I
暂无
中图分类号
R63 [外科感染];
学科分类号
1002 ; 100210 ;
摘要
Monocytes are effector immune cells but a precise analysis of their role in immune response has been precluded by their heterogeneity. Indeed,human monocytes are composed of at least three different subsets with different phenotypic characteristics and functional properties,the so-called classical,intermediate and nonclassical monocytes. A review of the literature shows that these monocyte subsets are differently affected during viral,bacterial,parasitic and fungal infections.The expansion of the CD16+ compartment(intermediate and non-classical monocytes) is typically observed in the majority of infectious diseases and the increased proportion of CD16+ monocytes is likely related to their activation through their direct interaction with the pathogen or the inflammatory context. In contrast,the number of non-classical and intermediate monocytes is decreased in Q fever endocarditis,suggesting that complex mechanisms govern the equilibrium among monocyte subsets. The measurement of monocyte subsets would be useful in better understanding of the role of monocyte activation in the pathophysiology of infectious diseases.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 50 条
  • [31] Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia
    Wang, Zhihua
    Yang, Lei
    Ye, Jing
    Wang, Yushui
    Liu, Yan
    IMMUNOLOGIC RESEARCH, 2019, 67 (4-5) : 373 - 381
  • [32] Interferon Lambda: Modulating Immunity in Infectious Diseases
    Syedbasha, Mohammedyaseen
    Egli, Adrian
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [33] A brief history of the prevention of infectious diseases by immunisations
    Bazin, H
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2003, 26 (5-6) : 293 - 308
  • [34] Do infectious diseases drive MHC diversity?
    Jeffery, KJM
    Bangham, CRM
    MICROBES AND INFECTION, 2000, 2 (11) : 1335 - 1341
  • [35] Advances of Raman Spectroscopy in Diagnosis of Infectious Diseases
    Li Yan
    Qi Yu
    Li He
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2022, 50 (03) : 317 - 374
  • [36] Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases
    Assinger, Alice
    Capron, Claude
    Real, Fernando
    Bomsel, Morgane
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Olfactomedin 4 Is a Biomarker for the Severity of Infectious Diseases
    Liu, Wenli
    Rodgers, Griffin P.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (04):
  • [38] Paraoxonases and infectious diseases
    Camps, Jordi
    Iftimie, Simona
    Garcia-Heredia, Anabel
    Castro, Antoni
    Joven, Jorge
    CLINICAL BIOCHEMISTRY, 2017, 50 (13-14) : 804 - 811
  • [39] Dynamics of infectious diseases
    Rock, Kat
    Brand, Sam
    Moir, Jo
    Keeling, Matt J.
    REPORTS ON PROGRESS IN PHYSICS, 2014, 77 (02)
  • [40] Vasculitis and infectious diseases
    Satta, R.
    Biondi, G.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2015, 150 (02): : 211 - 220